Amarin Corp Plc (AMRN)

[alm2]

ralphy
Whist Dr reddy may have intended to enter the market they can see first hand that litigation could await them as to infringement if they did and over and above there are clearly issues facing generics (as per Hikma) as to supply
One suspects that no other generic will wish to enter the market until litigation is over - a years wait for example
-Would probably be enough to allow the litigation to clear -if Amarin fails in litigation on the three fronts they can then come into the market without concern
So I doubt anyone else will join the generic party for a long time -and let us hope never on the basis of success in litigation
Alm